サマリー

降圧剤の世界市場 2022-2026 年
Technavioは降圧剤市場を監視しており、2022-2026年の間に58億7000万ドルの成長が見込まれ、予測期間中にCAGR3.1％で加速しています。当レポートでは、降圧剤市場の全体的な分析、市場規模と予測、トレンド、成長ドライバー、課題、さらに約25社のベンダーを網羅したベンダー分析などを提供しています。
現在の世界市場のシナリオ、最新動向とドライバー、市場全体の環境について最新の分析を提供しています。市場は、幅広い薬剤の入手可能性、高血圧の危険因子を持つ人口の増加、高血圧に関する研究資金の増加によって牽引されています。
降圧剤市場の分析には、タイプ別セグメントと地域別の展望が含まれます。
Technavioの降圧剤市場は、以下のようにセグメント化されています。
タイプ別
- 全身性高血圧
- 肺高血圧症
地域別
- 北米
- 欧州
- アジア
- その他の地域 (ROW)
本調査では、今後数年間の降圧剤市場の成長を牽引する主な要因の一つとして、放出制御製剤の開発を挙げています。また、新規分子の開発と冠状動脈性心臓病（CHD）の強い発生率が、市場の大きな需要につながると考えられます。
Technavioは、複数のソースからのデータを調査、合成、総括する方法で、主要パラメータの分析により、市場の詳細な姿を提示します。降圧剤市場に関する当レポートは、以下の分野をカバーしています。
- 降圧剤市場のサイジング
- 降圧剤市場の予測
- 降圧剤市場の産業分析
Technavioの強力なベンダー分析は、顧客が市場での地位を向上できるように設計されており、これに沿って本レポートでは、Abbott Laboratories、AstraZeneca Plc、Aurobindo Pharma Ltd. 、Bausch Health Co Inc、Bayer AG、Cipla Ltd.、第一三共 Co., Ltd.を含むいくつかの主要降圧剤市場ベンダーに関する詳細分析を提供しています。ジョンソン・アンド・ジョンソン、ルパン、メルク・アンド・カンパニー、ノルデン・ファーマ、オーロリンド・ファーマ、バウシュ・ヘルス、バイエル、シプラ、第一三共、ドクター・レディス・ラボラトリーズ、グラクソ・スミスクライン、ヘテロ・ヘルスケア、ジョンソン・アンド・ジョンソンInc.、Norden Pharma DAC、Novartis AG、Pfizer Inc.、Sanofi SA、Sun Pharmaceutical Industries Ltd、Viatris Inc、Zydus Lifesciences Ltd.の7社です。また、降圧剤市場の分析レポートには、今後の動向と市場成長に影響を与える課題に関する情報も含まれています。これは、企業が戦略を立て、今後訪れるすべての成長機会を活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含む一次情報および二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/antihypertensive-drugs-market-industry-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数のソースからのデータの研究、合成、総括の方法により、市場の詳細な姿を提示します。また、業界の主要なインフルエンサーを特定することにより、市場の様々な側面を提示しています。提示されるデータは、包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
o Exhibit 06: Executive Summary - Chart on Incremental Growth
o Exhibit 07: Executive Summary - Data Table on Incremental Growth
o Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
• 5 Market Segmentation by Type
o 5.1 Market segments
o Exhibit 24: Chart on Type - Market share 2021-2026 (%)
o Exhibit 25: Data Table on Type - Market share 2021-2026 (%)
o 5.2 Comparison by Type
o Exhibit 26: Chart on Comparison by Type
o Exhibit 27: Data Table on Comparison by Type
o 5.3 Systemic hypertension - Market size and forecast 2021-2026
o Exhibit 28: Chart on Systemic hypertension - Market size and forecast 2021-2026 ($ million)
o Exhibit 29: Data Table on Systemic hypertension - Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Chart on Systemic hypertension - Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on Systemic hypertension - Year-over-year growth 2021-2026 (%)
o 5.4 Pulmonary hypertension - Market size and forecast 2021-2026
o Exhibit 32: Chart on Pulmonary hypertension - Market size and forecast 2021-2026 ($ million)
o Exhibit 33: Data Table on Pulmonary hypertension - Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Chart on Pulmonary hypertension - Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on Pulmonary hypertension - Year-over-year growth 2021-2026 (%)
o 5.5 Market opportunity by Type
o Exhibit 36: Market opportunity by Type ($ million)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
o Exhibit 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 40: Chart on Geographic comparison
o Exhibit 41: Data Table on Geographic comparison
o 7.3 North America - Market size and forecast 2021-2026
o Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
o Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
o 7.4 Europe - Market size and forecast 2021-2026
o Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
o Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
o 7.5 Asia - Market size and forecast 2021-2026
o Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
o Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o 7.7 US - Market size and forecast 2021-2026
o Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
o 7.8 Germany - Market size and forecast 2021-2026
o Exhibit 62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 64: Chart on Germany - Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
o 7.9 UK - Market size and forecast 2021-2026
o Exhibit 66: Chart on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 67: Data Table on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 68: Chart on UK - Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on UK - Year-over-year growth 2021-2026 (%)
o 7.10 China - Market size and forecast 2021-2026
o Exhibit 70: Chart on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 71: Data Table on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 72: Chart on China - Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on China - Year-over-year growth 2021-2026 (%)
o 7.11 Japan - Market size and forecast 2021-2026
o Exhibit 74: Chart on Japan - Market size and forecast 2021-2026 ($ million)
o Exhibit 75: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
o Exhibit 76: Chart on Japan - Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on Japan - Year-over-year growth 2021-2026 (%)
o 7.12 Market opportunity By Geographical Landscape
o Exhibit 78: Market opportunity By Geographical Landscape ($ million)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 79: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 81: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 82: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 83: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 84: Matrix on vendor position and classification
o 10.3 AstraZeneca Plc
o Exhibit 85: AstraZeneca Plc - Overview
o Exhibit 86: AstraZeneca Plc - Product / Service
o Exhibit 87: AstraZeneca Plc - Key news
o Exhibit 88: AstraZeneca Plc - Key offerings
o 10.4 Bayer AG
o Exhibit 89: Bayer AG - Overview
o Exhibit 90: Bayer AG - Business segments
o Exhibit 91: Bayer AG - Key offerings
o Exhibit 92: Bayer AG - Segment focus
o 10.5 Dr Reddys Laboratories Ltd
o Exhibit 93: Dr Reddys Laboratories Ltd - Overview
o Exhibit 94: Dr Reddys Laboratories Ltd - Business segments
o Exhibit 95: Dr Reddys Laboratories Ltd - Key offerings
o Exhibit 96: Dr Reddys Laboratories Ltd - Segment focus
o 10.6 GlaxoSmithKline Plc
o Exhibit 97: GlaxoSmithKline Plc - Overview
o Exhibit 98: GlaxoSmithKline Plc - Business segments
o Exhibit 99: GlaxoSmithKline Plc - Key news
o Exhibit 100: GlaxoSmithKline Plc - Key offerings
o Exhibit 101: GlaxoSmithKline Plc - Segment focus
o 10.7 Johnson and Johnson
o Exhibit 102: Johnson and Johnson - Overview
o Exhibit 103: Johnson and Johnson - Business segments
o Exhibit 104: Johnson and Johnson - Key news
o Exhibit 105: Johnson and Johnson - Key offerings
o Exhibit 106: Johnson and Johnson - Segment focus
o 10.8 Lupin Ltd
o Exhibit 107: Lupin Ltd - Overview
o Exhibit 108: Lupin Ltd - Product / Service
o Exhibit 109: Lupin Ltd - Key news
o Exhibit 110: Lupin Ltd - Key offerings
o 10.9 Merck and Co. Inc.
o Exhibit 111: Merck and Co. Inc. - Overview
o Exhibit 112: Merck and Co. Inc. - Business segments
o Exhibit 113: Merck and Co. Inc. - Key news
o Exhibit 114: Merck and Co. Inc. - Key offerings
o Exhibit 115: Merck and Co. Inc. - Segment focus
o 10.10 Novartis AG
o Exhibit 116: Novartis AG - Overview
o Exhibit 117: Novartis AG - Business segments
o Exhibit 118: Novartis AG - Key offerings
o Exhibit 119: Novartis AG - Segment focus
o 10.11 Pfizer Inc.
o Exhibit 120: Pfizer Inc. - Overview
o Exhibit 121: Pfizer Inc. - Product / Service
o Exhibit 122: Pfizer Inc. - Key news
o Exhibit 123: Pfizer Inc. - Key offerings
o 10.12 Sanofi SA
o Exhibit 124: Sanofi SA - Overview
o Exhibit 125: Sanofi SA - Business segments
o Exhibit 126: Sanofi SA - Key news
o Exhibit 127: Sanofi SA - Key offerings
o Exhibit 128: Sanofi SA - Segment focus
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 129: Inclusions checklist
o Exhibit 130: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 131: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 132: Research methodology
o Exhibit 133: Validation techniques employed for market sizing
o Exhibit 134: Information sources
o 11.5 List of abbreviations
o Exhibit 135: List of abbreviations
o health: Includes veterinary drugs (excluded from the scope of the report)


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Type
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between 2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Type - Market share 2021-2026 (%)
Exhibits25: Data Table on Type - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Type
Exhibits27: Data Table on Comparison by Type
Exhibits28: Chart on Systemic hypertension - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Systemic hypertension - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Systemic hypertension - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Systemic hypertension - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Pulmonary hypertension - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Pulmonary hypertension - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Pulmonary hypertension - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Pulmonary hypertension - Year-over-year growth 2021-2026 (%)
Exhibits36: Market opportunity by Type ($ million)
Exhibits37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits38: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits40: Chart on Geographic comparison
Exhibits41: Data Table on Geographic comparison
Exhibits42: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits45: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits48: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on Japan - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on Japan - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on Japan - Year-over-year growth 2021-2026 (%)
Exhibits78: Market opportunity By Geographical Landscape ($ million)
Exhibits79: Impact of drivers and challenges in 2021 and 2026
Exhibits80: Overview on Criticality of inputs and Factors of differentiation
Exhibits81: Overview on factors of disruption
Exhibits82: Impact of key risks on business
Exhibits83: Vendors covered
Exhibits84: Matrix on vendor position and classification
Exhibits85: AstraZeneca Plc - Overview
Exhibits86: AstraZeneca Plc - Product / Service
Exhibits87: AstraZeneca Plc - Key news
Exhibits88: AstraZeneca Plc - Key offerings
Exhibits89: Bayer AG - Overview
Exhibits90: Bayer AG - Business segments
Exhibits91: Bayer AG - Key offerings
Exhibits92: Bayer AG - Segment focus
Exhibits93: Dr Reddys Laboratories Ltd - Overview
Exhibits94: Dr Reddys Laboratories Ltd - Business segments
Exhibits95: Dr Reddys Laboratories Ltd - Key offerings
Exhibits96: Dr Reddys Laboratories Ltd - Segment focus
Exhibits97: GlaxoSmithKline Plc - Overview
Exhibits98: GlaxoSmithKline Plc - Business segments
Exhibits99: GlaxoSmithKline Plc - Key news
Exhibits100: GlaxoSmithKline Plc - Key offerings
Exhibits101: GlaxoSmithKline Plc - Segment focus
Exhibits102: Johnson and Johnson - Overview
Exhibits103: Johnson and Johnson - Business segments
Exhibits104: Johnson and Johnson - Key news
Exhibits105: Johnson and Johnson - Key offerings
Exhibits106: Johnson and Johnson - Segment focus
Exhibits107: Lupin Ltd - Overview
Exhibits108: Lupin Ltd - Product / Service
Exhibits109: Lupin Ltd - Key news
Exhibits110: Lupin Ltd - Key offerings
Exhibits111: Merck and Co. Inc. - Overview
Exhibits112: Merck and Co. Inc. - Business segments
Exhibits113: Merck and Co. Inc. - Key news
Exhibits114: Merck and Co. Inc. - Key offerings
Exhibits115: Merck and Co. Inc. - Segment focus
Exhibits116: Novartis AG - Overview
Exhibits117: Novartis AG - Business segments
Exhibits118: Novartis AG - Key offerings
Exhibits119: Novartis AG - Segment focus
Exhibits120: Pfizer Inc. - Overview
Exhibits121: Pfizer Inc. - Product / Service
Exhibits122: Pfizer Inc. - Key news
Exhibits123: Pfizer Inc. - Key offerings
Exhibits124: Sanofi SA - Overview
Exhibits125: Sanofi SA - Business segments
Exhibits126: Sanofi SA - Key news
Exhibits127: Sanofi SA - Key offerings
Exhibits128: Sanofi SA - Segment focus
Exhibits129: Inclusions checklist
Exhibits130: Exclusions checklist
Exhibits131: Currency conversion rates for US$
Exhibits132: Research methodology
Exhibits133: Validation techniques employed for market sizing
Exhibits134: Information sources
Exhibits135: List of abbreviations